Resazurin rapid screening for antibacterial activities of organic and inorganic nanoparticles: Potential, limitations and precautions.

Nanoparticles have been used as antibacterial agents in several products. To optimize their effectiveness, synthesis processes and particle modifications have been developed, creating the need for a rapid screening method to investigate their potencies. Owing to the opacity and insolubility of nanoparticles, a classical method to determine antibacterial activity-such as the minimum inhibitory concentration (MIC), which relies on turbidimetry-might not apply to them. In this study, we demonstrate the potential of a dye (resazurin)-based assay as an indicator of bacterial growth to rapidly screen the antibacterial activities of both organic and inorganic nanomaterials against both gram-negative (E. coli) and gram-positive (S. aureus) bacteria. The results indicate that the resazurin-based assay successfully determine the MIC of organic lipid nanocarriers, and several inorganic nanoparticles. However, the use of resazurin require a precaution for nanoparticles with photocatalytic properties, which may cause dye degradation at higher concentrations. In this study, resazurin bleaching was observed at approximately >50 mg/ml of TiO2. In summary, the modified MIC assay with resazurin can evaluate antibacterial activity of nanomaterials, whose turbidity interferer conventional MIC assay. This modification conserves an advantage of MICs assay which are simple and reliable. This would be useful for screening of antibacterial nanomaterials.

Self-calcifying lipid nanocarrier for bone tissue engineering.

BACKGROUND: A nanoemulsion with specific surface properties (such as charge and functional groups) can initiate the deposition of calcium phosphate (CaP) on its surface, leading to formation of CaP nanoparticles with a lipid core. The lipid core can carry lipophilic compounds based on the function of the nanoemulsion. Therefore, a dual purpose nanoemulsion of lipid nanoparticles (LNPs) exhibiting self-calcifying and carrier abilities can be developed. METHODS: We employed an emulsification process to formulate LNPs with a specific charged surface. The LNPs were tested for their ability to calcify in simulated body fluid and encapsulate cholecalciferol (a model of active compound). The self-calcifying LNP was successfully fabricated using the emulsification process and stabilized using a mixture of polysorbate 80 and polysorbate 20. RESULTS: The LNPs incubated in simulated body fluid bound to calcium and phosphate, subsequently forming CaP on the particle surface and resulting in approximately 180-nm CaP spheres with a lipid core. The LNPs facilitated calcium phosphate deposition in the collagen scaffolds. In addition, LNPs can be used as carriers of lipophilic compounds without impeding the self-calcifying ability.